chrisvoncsefalvay/vaers-outcomes huggingface dataset:
THIS 2 YR 2 MO OLD CAUCASIAN MALE WAS FOUND UNRESPONSIVE ANS ASSUMING BIZZARE POSTURES WITH TREMULOUSNESS SINCE THE MORNING OF 09/12/2008. HE WAS ADMINISTERED CATCH UP VACCINES ON 09/09/2008 WHICH ARE DTaP/Hib/MMR1/VARICELLA1/PCV. NO HISTORY OF FEVER/VOMITING/DIARRHEA/SEIZURES/RASH. BUT GRAND MOM, WHO IS A NURSE, REPORTED THE CHILD HAVING CHILLS SINCE THE MORNING OF 09/12/2008. KID HAD MULTIPLE MOSQUITO BITES ALL OVER HIS BODY. ACCORDING TO CONSULTANT NEUROLOGIST: THE PATIENT BEGAN DISPLAYING BEHAVIORAL CHANGES ON FRIDAY, 09-12-2008 WITH LOSS OF LANGUGAE ABILITIES AND LETHARGY OR INATTENTIVENESS. HE SEEMED TO ENGAGE IN SOME" STARING" BEHAVIOR. NO FEVER OR CONVULSIVE SEIZURE ACTIVITY NOTED. 0N 09-14-2008, NEUROLOGIC STATUS HAS IMPROVED. THE PATIENT SEEMS TO BE RETURNING TO HIS HEALTHY BASELINE. HE STILL APPEARS SLIGHLTY "UNSTEADY AND SHAKY", AS CORROBORATED BY HIS MOTHER. HE IS NOW TALKING SOME, EATING, PLAYING AND ENGAGING WITH HIS ENVIRONMENT. HE HAS NO CLOUDING OF SENSORIUM. HE REMAINS SEIZURE FREE DESPITE BEING ON ANY ANTI CONVULSANT. EEG IS PLANNED TODAY 09/15/2008. THIS MORNING HE IS QUITE ACTIVE BUT STILL A LITTLE SWAYING IS PRESENT IN HIS GAIT PROBABLY DUE TO CERBELLAR ATAXIA.
Was fatigued and had headache since about hour after shot day before, and was nauseated morning after shot but was tollerable.  About 1 pm was sitting at my desk when felt flush and neck hurt. Noted rash across neck and upper torso, swelling at lymph node L side neck area. Area was painful to light touch. Pt (self) went to urgent care to be further evaluated by someone else other than patient, once there began to get worse.  All over tingling but significant at fingers, toes and mouth lips. Unable to talk clearly, but never  became confused. So tired unable to stay awake; difficult to rouse. No difficulty with breathing; Epi was not needed or given. Transported to hospital via EMS due to inability to stay awake and difficulty speaking/unable to stand without assistance. It was very hard to talk - to get the words out - but I never did have any decline in mental thought process and was never disorientated. Looked intoxicated however.  At hospital when pt transferred from stretcher to bed, pt doubled over due to abdominal discomfort - it was where the EKG stickers were. All reflexes noted to be hyper - MD kicked on accident when checking reflexes. the EKG stickers felt like being punched or slapped. Needed assistance transferring. All over numbness/tingling noted. Breathing never affected. Symptoms resolved after a few hours.
Information has been received from a health professional concerning a 6 year old female who on 12/09/1998 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot #625047/1574E).  Subsequently in February 2004, the patient experienced breakthrough chickenpox.  It was reported that there was a total of 45 cases of breakthrough in the patient's school, including the patient, and 17 were vaccine recipients.  Unspecified medical attention was sought.  There was no product quality complaint involved.  The reporter indicated that 16 other patients had similar experiences following exposure to varicella virus vaccine live.  Additional information has been requested.
Pt had severe local site injection reaction. Was deep red and warm to touch. Pt did not report any systemic fever as of 12/5/17.
Information has been received from a registered nurse concerning a patient who on 30-JAN-1997 was vaccinated with a dose of Varivax. Subsequently, on 15-MAR-2006, the patient developed breakthrough varicella. Unspecified medical attention was sought. There was no product quality complaint. No additional information is expected.
Pain in muscle where injection occurred.  Shooting pain and unable to raise arm to put on shirt, pain when sleep on that side, quick movements of that are painful, can no longer lift heavy weight.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/13/2021 and 2/8/2021. Presented to the ED on 1/1/2022 with complaints of shortness of breath, weakness, and coughing approximately 2 weeks, reports fever and chills for past two days. During hospitalization patient also noted to have aspiration pneumonitis secondary to dilated esophagus with food debris impacted to wall. Treated with zosyn, steroids and O2. Condition conditued to deteriorate and expired on 1/5/2022.
This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested. On 14-MAR-2021, the subject experienced body ache. On 14-MAR-2021, the subject experienced dizziness. On 14-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, dizziness, chills, and headache on 15-MAR-2021. This report was non-serious.
JAW PAIN; ELEVATED HEART; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced jaw pain, elevated heart, chills, headache, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, chills, fever, elevated heart and jaw pain was not reported. This report was non-serious.
Pt c/o feeling dizzy, nauseous, lightheaded about 10 mins after receiving first dose of Pfizer vaccine. RN came to assess patient, patient looked pale and diaphoretic. Ice pack applied to back of neck, ice water given, feet propped on second second and fan faced toward patient. Pt states she did have a light breakfast in the morning was anxious about the vaccine prior to receiving it. VS were taken immediately at 1152: 76/46 (54), HR 62, 98% SpO2 on RA. Pt A&O x4.  RN STAT was called at 1155. Pt's VS were taken a second time at 1155: 112/56 (72), HR 65. Pt stated she was feeling better but pt was still pale and diaphoretic. Pt refused to transfer via gurney and felt safe to transfer via wheelchair to treatment room.
Pt recv vax on 9/25/97; on 9/26/97 pt exp induration of vax site & swollen arm; pt imp 9/30/97.
This was the Spikevax vaccine - not listed above. Headache and aches in all large joints, heart palpitations, headache intensified during the night, chills, sweats, aches intensified. By morning headache had become a migraine followed by vomiting after which headache became more mild helped by ibuprofen. Headache, tho mild, continues to next day. General malaise.
Pt was given moderna vaccine on 4/23. 6 Hours later had nausea, vomiting, chills, and development of chest pain. Most symptoms disappeared within 6 hours save for the chest pain, which got worse over 3 days time, until patient arrived in our emergency room.  The patient was found to have acute myopericarditis and was admitted to the pediatric intensive care unit. Had elevated troponin and EKG changes associated with myopericarditis. Started on anti inflammatories with good effect.
Patient had syncopal event with tonic clonic movements, convulsions, seizure, and in post ictal state had hypoxia to O2 sat of 72% placed on O2 brought up to 99%.
The patient is a 62-year-old female presented with complaints shortness of breath and cough.  The patient was found to have COVID pneumonia.  Initially the patient was requiring supplementary oxygen to maintain appropriate saturations.  She was started on therapy of Decadron, however fell outside of the time frame recommended for remdesivir.  With steroid therapy and symptomatic management the patient had improvement of her symptoms, although was noted to have persistent cough at time of discharge.  The patient had remained stable on room air for 24 hours prior to discharge.  CRP was noted to be down trending at time of discharge.  We discussed recommendations for ongoing management at home.
never had allergies to anything especially enviornmental/pollen. Severe runny nose and stuffiness ..noticed more when had car windows down on commute .. at workplace, different types of mask with same result... better when cloth mask on inside with N95 outside(cone type)....continue to have symptoms on exposure to pollen, better with masks after two months...used nasonex and claritin for symptomatic relief..symptomatic relief..did not work initially but better response now...
burning nerve pain; Stomach issues; This case was reported by a consumer via call center representative and described the occurrence of nerve pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced nerve pain and stomach discomfort. On an unknown date, the outcome of the nerve pain and stomach discomfort were unknown.   The reporter considered the nerve pain and stomach discomfort to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The reporter stated that the patient on an online forum reported that he/she developed burning nerve pain and stomach issues from receiving the Shingrix vaccine. The reporter did not consent to follow up. No further information was provided. This case had been linked with US2021038319, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021038319:same reporter
pt recv vax & started having a sore throat & congestion for 1wk;pt contacted MD & ATB were prescribed over the phone;pt has recovered;
I broke out in hives that lasted for three weeks they started on my chest and spread all over my torso up my neck and to my face. This happened within the first 3 hours after receiving the shot.
died; Dementia; This is a spontaneous report from a contactable consumer. This consumer reported similar event for two patients. This is the first of two reports. This is a spontaneous report from a contactable consumer. This consumer reported similar event for two patients. This is the second of two reports.  A 91-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no other vaccines in four weeks. The patient was not pregnant ("AS REPORTED"). It was reported that the patient at the board and care developed dementia like side effects on 22Mar2021 that didn't exist prior. It was also reported that the patient died on an unspecified date. The events required emergency room/department or urgent care and reported as life-threatening illness (immediate risk of death from the event). The patient had no COVID prior the vaccination and was not tested for COVID post vaccination. Therapeutic measures were taken as a result of the events which included hospice. The outcome of the event dementia was not recovered. It was not reported if an autopsy was performed.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021383789 Same reporter/drug/event, different patient.; Reported Cause(s) of Death: died
Rash, itchiness, soreness, and swelling (2? diameter) at the site of the injection, appeared one week after shot was given.
After administration of vaccine, we were notified that the vaccine had experienced a temperature monitoring event outside of our facility.  Patient was notified of guidelines that recommend revaccination.  Patient came in 10/13/2022 for revaccination.
mild sore throat; sinus pain; headache; cold s/s; Treatment of COVID-19; Treatment of COVID-19; fever; body aches; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Jan2021 as dose 1, single (Batch/Lot number: unknown), on 22Jan2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 15Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for COVID-19 immunization. The patient's relevant medical history included: "Cancer" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; LANREOTIDE, start date: 16May2022, stop date: 16May2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19"; SINUS PAIN (non-serious), outcome "unknown"; HEADACHE (non-serious), outcome "unknown"; NASOPHARYNGITIS (non-serious), outcome "unknown", described as "cold s/s"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "mild sore throat"; PAIN (non-serious), outcome "recovered", described as "body aches"; PYREXIA (non-serious), outcome "recovered", described as "fever". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (31May2022) Positive. Therapeutic measures were taken as a result of covid-19, sinus pain, headache, nasopharyngitis, oropharyngeal pain. Clinical course: It was reported that, day 7 after completing Paxlovid patient started with her prev COVID s/s; sinus pain, headache, and then cold s/s, mild sore throat. These symptoms were mild compared to her initial COVID course. With her initial COVID course she also had body aches, and fever for 24 hrs. She tested on 31May2022, 2 days after rebound s/s and her home test was quickly positive. Patient received Paxlovid as treatment of COVID-19; start of drug: 17May2022 and date of last administration: 21May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported COVID-19 positive after both the doses of COVID-19 immunization is considered as vaccination failure of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
TDaP given to pt. before RN noted that he had received a TDaP in 2015. No adverse reaction noted.
Fatigue tension headache, very low-grade fever (99.5 deg F), mild chills, moderate fleeting disorientation, also mild caffeine intolerance. All symptoms low severity, persistent for less than 24 hrs so far. Far more mild reaction than to prior booster shot (Nov 2021 ? Moderna Lot 012F21A) or to two primary doses (April and May 2021 ? Moderna 032B21A and W5C21A )
Dizziness the morning after the shot. Fatigue for all days since the shot. Three days after the shot, sensations from, I believe, my heart down into my abdomen - it felt like a mildly painful linear contraction from just left of my sternum down about 4", happened about 5 times within a minute or two and stopped, no similar events since.
Pt was having tingling of the tongue and trouble breathing. Pt was given a 25mg benadryl and it was helping.
diarrhea, not completely runny, but not real firm, more like soft and mushy, not normal; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (diarrhea, not completely runny, but not real firm, more like soft and mushy, not normal) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced DIARRHOEA (diarrhea, not completely runny, but not real firm, more like soft and mushy, not normal). The patient was treated with AMMONIUM CHLORIDE at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea, not completely runny, but not real firm, more like soft and mushy, not normal) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication dicyclomime 10mg was prescribed but not taken.  Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
27Mar91 100pm-T 100,gave Pediacare, 400pm-T 104, gave APAP, 730pm-unresponsive"white as a sheet",lips&nail beds black.Taken to ER & admitted to ICU.29Mar-91 D/C-advised not to give DPT
arm was sore; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. Medical history included Crohn's disease. The patient's concomitant medications were not reported. The patient experienced arm was sore on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible; information on the lot/batch number cannot be obtained. No further information is expected.
RECEIVED HALF DOSE FOR BOOSTER; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 47 year old male male of unspecified race and ethnic origin.   The patient's weight, height, and medical history were not reported.  On an unspecified date, the patient previously received covid-19 vaccine ad26.cov2.s vaccination from an unspecified manufacturer (suspension for injection, route of admin not reported, batch number: unknown expiry: UNKNOWN) dose was not reported, 1 in total, (dose number in series: 1) for prophylactic vaccination and it was unknown whether patient had any adverse events.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A expiry: UNKNOWN) dose was not reported, 1 in total, (dose number in series: 2), administered on 27-NOV-2021 for prophylactic vaccination   The patient received half dose for booster (Off label use)  (dose number in series: 2). No concomitant medications were reported.   The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The outcome of the received half dose for booster and off label use was not reported.  This report was non-serious.  This case, from the same reporter is linked to 20211202250, 20211201046, 20211201228, 20211201168, 20211202193, 20211200717, 20211200723, 20211200769, 20211200994, 20211201179, 20211201286, 20211201304, 20211201351, 20211201362, 20211201392, 20211201443, 20211201450, 20211201963, 20211202161, 20211202199, 20211202207, 20211202246, 20211202371 and 20211202379. .
Patient received MMR, Varicella, and HIB on 7-21-04. Five days later developed fevers as high at 104 that lasted 3 days. He presented to my office on 7-29 with a red maculopapular rash on face, chest, and back. fevers resolved over 24hrs prior. rash is not pruritic.
Patient came up to counter, stated he felt dizzy. Leaning to the left. Assisted patient into the chair. Patient proceeded to lose consciousness. Sternal rub ineffective. Weak pulse. Called for FNP (Clinic manager) who brought out Ammonia after assessing the patient. Patient came back around after approximately 60 seconds. Patient did lose control of bladder. Once patient came to, assited to lying down in an exam room for further observation. Patient ambulated out of clinic with father after about 45 minutes.
admitted to a Birth Center for induction of labor for fetal growth restriction and elevated dopplers. Her pregnancy was complicated by GDMA1, history of preeclampsia, and COVID-19 positive screen on HCF admission.
Event: R shoulder SLAP tear, R Subacromial impingement. Treatment: 3/24/17 surgery (R shoulder arthroscopy, Subacromial decompression with acromioplasty, open subpectoral biceps tenodesis).
pt died 48 hrs p/2nd immun w/HBOC; COD given as SIDS; pt recvd vax @ 2, 4, & 6 mo not simultaneous w/HIB-TITER;
Sore arm, then hot red rash on arm next day That night, 102 fever with shivering and chills and aching body That night - Heavy sweats - had to change bedsheets
Information has been received from a physician concerning a currently 32 year old female patient who as a child had received a primary series of MMR vaccine live (lot # not reported) and subsequently had a negative titer. Unspecified medical attention was sought. No further information is available. It was also reported that the patient had received 3 booster doses of rubella virus vaccine live and the patient's antibody titer was still negative (WAES #0309USA1993).  This is in follow-up to report (s) previously submitted on 11/26/2003. Information has been received from a physician concerning a 31 year old female patient with a history of 2 miscarriages who in 2001 was vaccinated with a booster dose of rubella virus vaccine live (Wistar RA 27/3) (lot# not available) . It was reported that the patient had received  2 other booster doses of rubella from different doctors in 1999 and 2001 and the patient had been given a primary series of "MMR" as a child. The physician reported on 16-SEP-2003 that he had just done an antibody titer and it was still negative. Laboratory evaluation revealed a rubella antibody titer was negative. The physician reported he planned to order another antibody titer. No further information is available. It was reported that the patient had a negative titer following vaccination with MMR II (WAES# 0309USA02392).
Moderna COVID?19 Vaccine EUA Got vaccine 4pm.  I ate dinner at 6pm.  At 8pm felt slightly nauseous.  By 9pm it was worse.  By 9 30pm I was nauseous and full blow stomach pain.  My stomach was 'roiling or churning.'   Then between 9 30pm and 2 30am the next day I was nauseous, had stomach pain, I felt hot and cold and my head became more congested and I got a headache.  Note: the head congestion was there prior to getting the vaccine, but it got worse.   I sipped water throughout and it felt like I had to vomit (but I did not vomit).   I took my temperature a few times it ranged from 98 to 98.8.   My normal temperature is 97 to 97.5.   By morning, or about 4am the worse symptoms were gone.  My stomach felt more or less ok and at 7am  I ate a light breakfast without incident.   My temperature seemed to be elevated through the day.  I felt somewhat weak during the day.  Worst effects seem gone by Jan 8 evening.   The only effect left is pain in my left upper arm.  I consider these to be significant and worrying side effects and I may not take the second dose.
7 or 8 days after the second dose of the injection a rash covered my entire body and was very itchy .   Went to  doctor on April 27 and he prescribed prednisone 10 mg for 20 days.  Also Fluocinonide cream for itch 0.05 % 60 grams   I have one more day of prescription and still have rash and itch.